In our study, we demonstrated for the first time that both IMT and NIPPV treatment significantly reduced the levels of MDA and ROS in the serum of COPD patients, enhanced the activities of SOD and GSH, and significantly enhanced the antioxidant capacity of COPD patients. This evidence concerns the gene SOD1 and chronic obstructive pulmonary disease.